Clinical trial
Effects Of Oral Alfacalcidol On Maturation Of Dendritic Cells In Graves' Disease Patients
NCT02993302 is registered in ClinicalTrials.gov with Dr Cipto Mangunkusumo General Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effects Of Oral Alfacalcidol On Maturation Of Dendritic Cells In Graves' Disease Patients
- Lead sponsor
- Dr Cipto Mangunkusumo General Hospital
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- July 31, 2014
- Completion date
- March 31, 2015
- Enrollment
- 25 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.